2.An immunohistochemical evaluation of c-erbB-2 expression in epithelial ovarian cancer.
Kyung Tai KIM ; Sam Hyun CHO ; Youn Yeoung HWANG ; Hyung MOON ; Jai Auk LEE ; Young Hye KO ; Jung Dal LEE
Korean Journal of Obstetrics and Gynecology 1993;36(8):3334-3342
No abstract available.
Ovarian Neoplasms*
3.Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.
Journal of Gynecologic Oncology 2012;23(2):75-77
No abstract available.
Ovarian Neoplasms
4.Clinical significance of postoperative CA-125 level after primary cytoreductive surgery in ovarian cancer.
Journal of Gynecologic Oncology 2008;19(4):279-279
No abstract available.
Ovarian Neoplasms
5.Clinical significance of postoperative CA-125 level after primary cytoreductive surgery in ovarian cancer.
Journal of Gynecologic Oncology 2008;19(4):279-279
No abstract available.
Ovarian Neoplasms
6.Role and clinical application of next-generation sequencing (NGS) for ovarian cancer.
Myong Cheol LIM ; Leslie M RANDALL
Journal of Gynecologic Oncology 2017;28(4):e51-
No abstract available.
Ovarian Neoplasms*
7.Management of Advanced Epithelial Ovarian Cancer.
Korean Journal of Obstetrics and Gynecology 1999;42(8):1647-1654
No abstract available.
Ovarian Neoplasms*
8.A Short-Term In-Vitro Chemosensitivity Test for Ovarian Cancer: Nuclear Damage Assay.
Young Tak KIM ; Kwan Ja JI ; Yong Man KIM ; Joo Hyun NAM ; Jung Eun MOK
Korean Journal of Gynecologic Oncology and Colposcopy 1997;8(1):47-54
No abstract available.
Ovarian Neoplasms*
9.Do we need a better marker for successful ovarian cancer surgery?.
Journal of Gynecologic Oncology 2017;28(1):e21-
No abstract available.
Ovarian Neoplasms*
10.Recent advances in ovarian cancer treatment.
Journal of the Korean Medical Association 2016;59(3):164-166
No abstract available.
Ovarian Neoplasms*
Result Analysis
Print
Save
E-mail